What Happened?
Seattle, WA-based Impel NeuroPharma Appointed Michael Hite as Chief Executive Officer
About the Company
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
About the Person
Michael Hite is Chief Executive Officer at Impel NeuroPharma. Previously, Michael held various senior HR leadership roles in the industry.
Info Source
News
Short Profile